Decreased serum 1,5-anhydroglucitol in nondiabetic subjects with a family history of NIDDM
Decreased serum 1,5-anhydroglucitol in nondiabetic subjects with a family history of NIDDM. S Tsukui , Y Fukumura and I Kobayashi Department of Laboratory Medicine, Gunma University School of Medicine, Japan. pxk04327@niftyserve.or.jp Abstract OBJECTIVE: To investigate the effect of a family history...
Saved in:
Published in | Diabetes Caer Vol. 19; no. 9; pp. 940 - 944 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Alexandria, VA
American Diabetes Association
01.09.1996
|
Subjects | |
Online Access | Get full text |
ISSN | 0149-5992 1935-5548 |
DOI | 10.2337/diacare.19.9.940 |
Cover
Summary: | Decreased serum 1,5-anhydroglucitol in nondiabetic subjects with a family history of NIDDM.
S Tsukui ,
Y Fukumura and
I Kobayashi
Department of Laboratory Medicine, Gunma University School of Medicine, Japan. pxk04327@niftyserve.or.jp
Abstract
OBJECTIVE: To investigate the effect of a family history of NIDDM on HbAlc and serum 1,5-anhydroglucitol (AG) in nondiabetic
subjects. RESEARCH DESIGN AND METHODS: A 75-g oral glucose tolerance test was performed; 258 subjects with normal glucose
tolerance and 106 subjects with impaired glucose tolerance (IGT) were selected HbAlc and serum AG were compared between subjects
with and without a family history of NIDDM. The relationships between age, BMI, HbAlc, serum AG, fasting and 2-h plasma glucose,
and urinary glucose were also examined using principal component analysis with a varimax rotation. RESULTS: In the normal
group, only serum AG was lower in subjects with a positive family history than in those with no family history. On the other
hand, in the IGT group, subjects with a positive family history were younger and had a higher 2-h plasma glucose, a higher
urinary glucose, and a lower serum AG than those with no family history, whereas there was no difference in HbAlc. Principal
component analysis identified three factors. The first factor, a linear combination of HbAlc and fasting plasma glucose, was
labeled an average glycemic factor. The second factor, which included serum AG, 2-h plasma glucose, and urinary glucose, was
labeled an oscillatory glycemic factor. The third factor, which contrasted age against BMI, was labeled an environmental factor.
CONCLUSIONS: Serum AG is related to glycosuria even among nondiabetic subjects, and its concentrations are decreased in those
with a family history of NIDDM. Our results suggest that serum AG rather than HbAlc reflects early metabolic abnormalities
in these subjects. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-2 content type line 23 |
ISSN: | 0149-5992 1935-5548 |
DOI: | 10.2337/diacare.19.9.940 |